The endometrial cancer cell line AN3CA, which strongly expresses MIS/AMHRII when treated with MIS/AMH, upregulates the β-catenin-interacting protein (ICAT), which negatively regulates the Wnt signaling pathway by inhibiting the interaction between β-catenin and TCF family members 17. The gene discussed is AMH; the disease is endometrial cancer.